Graves甲亢患者<sup>131</sup>I治疗后早期TRAb及TSAb变化的研究分析

梁雯丽; 郑艳; 李娜; 赵德善; 梁雯丽; 郑艳; 李娜; 赵德善

doi:10.3760/cma.j.issn.1673-4114.2016.01.003

[1]

Takamura Y, Nakano K, Uruno T, et al.Changes in serum TSH receptor antibody(TRAb) values in patients with Graves' disease after total or subtotal thyroidectomy[J].Endocr J, 2003, 50(5):595-601.DOI:http://doi.org/10.1507/endocrj.50.595.

[2]

Jang SY, Shin DY, Lee EJ, et al.Correlation between TSH receptor antibody assays and clinical manifestations of Graves' orbitopathy[J].Yonsei Med J, 2013, 54(4):1033-1039.DOI:10.3349/ymj.2013.54.4.1033.

[3]

Matthews DC, Syed AA.The role of TSH receptor antibodies in the management of Graves' disease[J].Eur J Intern Med, 2011, 22(3):213-216.DOI:10.1016/j.ejim.2011.02.006.

[4]

冯凭.Graves病的诊断与治疗[J].国外医学:内分泌学分册, 2004, 24(1):68-69, 72.DOI:10.3760/cma.j.issn.1673-4157.2004.01.026.
Feng P.Diagnosis and treatment of Graces[J].Section Endocrinol Foreign Med Sci, 2004, 24(1):68-69, 72. doi: 10.3760/cma.j.issn.1673-4157.2004.01.026

[5]

钟兴祥, 郑吉祥, 蓝冠章, 等.Graves甲亢¹³¹I治疗前后血清TRAb动态变化及临床价值[J].国际放射医学核医学杂志, 2011, 35(2):110-113.DOI:10.3760/cma.j.issn.1673-4114.2011.02.011.
Zhong XX, Zheng JX, Lan GZ, et al.Changes of serum TRAb after ¹³¹I radiotherapy in patients of Graves hyperthyroidism[J].Int J Radiat Med Nucl Med, 2011, 35(2):110-113. doi: 10.3760/cma.j.issn.1673-4114.2011.02.011

[6]

Lantz M, Planck T, Asman P, et al.Increased TRAb and/or low anti-TPO titers at diagnosis of graves' disease are associated with an increased risk of developing ophthalmopathy after onse[J].Exp Clin Endocrinol Diabetes, 2014, 122(2):113-117.DOI:10.1055/s-0033-1363193.

[7]

Smith BR, Sanders J, Furmaniak J.TSH receptor antibodies[J].Thyroid, 2007, 17(10):923-938.DOI:10.1089/thy.2007.0239.

[8]

Massart C, Sapin R, Gibassier J, et al.Intermethod variability in TSH-Receptor antibody measurement:implication for the diagnosis of graves disease and for the Follow-Up of graves ophthalmopathy[J].Clin Chem, 2009, 55(1):183-186.DOI:10.1373/clinchem.2008.115162.

[9]

Costagliola S, Morgenthaler NG, Hoermann R, et al.Second Generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease[J].J Clin Endocrinol Metab, 1999, 84(1):90-97.DOI:http://dx.doi.org/10.1210/jcem.84.1.5415#sthash.3Zfyif5k.dpuf.

[10]

Maugendre D, Massart C.Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease.Comparison with thyroid stimulating antibody bioassay[J].Clin Endocrinol(Oxf), 2001, 54(1):89-96.DOI:10.1046/j.1365-2265.2001.01197.x.

[11]

Takasu N, Yamada T, Takasu M, et al.Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis[J].N Engl J Med, 1992, 326(8):513-518.DOI:10.1056/NEJM199202203260803.

[12]

Takasu N, Oshiro C, Akamine H, et al.Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects[J].J Endocrinol Invest, 1997, 20(8):452-461. doi: 10.1007/BF03348001

[13]

Kung AW, Lau KS, Kohn LD.Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive Iodine therapy[J].Thyroid, 2000, 10(10):909-917.DOI:10.1089/thy.2000.10.909.

[14]

Kamath C, Adlan MA, Premawardhana LD.The role of thyrotrophin receptor antibody assays in graves' disease[J/OL].J Thyroid Res, 2012: 525936[2015-07-12].http://www.hindawi.com/journals/jtr/2012/525936/.DOI:10.1155/2012/525936.

[15]

张会娟, 李道明, 高冬玲, 等.Graves病异常表达HLA-DR抗原的甲状腺上皮细胞与血清TSAb的关系[J].中华内分泌代谢杂志, 2005, 21(6):546-547.DOI:10.3760/j.issn:1000-6699.2005.06.023.
Zhang HJ, Li DM, Gao DL, et al.Relationship between abnormal expression of HLA-DR antigen in thyroid epithelial cell and serum thyroid-stimulating antibodies in Graves'disease[J].Chin J Endocrinol and Metab, 2005, 21(6):546-547. doi: 10.3760/j.issn:1000-6699.2005.06.023

[16]

Weetman AP.Thyrotoxicosis[J].Medicine, 2013, 41(9):540-545.DOI:10.1016/j.mpmed.2013.06.012.

[17]

Yoshida K, Aizawa Y, Kaise N, et al.Role of thyroid-stimulating blocking antibody in patients who developed hypothyroidism within one year after ¹³¹I treatment for Graves' disease[J].Clin Endocrinol(Oxf), 1998, 48(1):17-22.DOI:10.1046/j.1365-2265.1998.00330.x.